tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market

EyePoint Pharmaceuticals (EYPT) Income Statement

Compare
872 Followers

EyePoint Pharmaceuticals Income Statement

Last quarter (Q4 2024), EyePoint Pharmaceuticals's total revenue was $11.59M, a decrease of -17.39% from the same quarter last year. In Q4, EyePoint Pharmaceuticals's net income was $-41.40M. See EyePoint Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 43.27M$ 46.02M$ 41.40M$ 36.94M$ 34.44M
Gross Profit
$ 39.56M$ 41.39M$ 33.08M$ 28.76M$ 28.61M
Operating Expenses
$ 185.41M$ 115.05M$ 112.02M$ 84.04M$ 65.90M
Depreciation and Amortization
$ 1.54M$ 464.00K$ 2.45M$ 2.77M$ 2.65M
EBITDA
$ -129.23M$ -69.00M$ -96.62M$ -50.15M$ -35.49M
Operating Income
$ -145.85M$ -75.07M$ -78.94M$ -55.28M$ -37.29M
Other Income/Expenses
$ 15.07M$ 4.36M$ -2.62M$ -3.14M$ -8.10M
Pretax Income
$ -130.78M$ -70.71M$ -102.25M$ -58.42M$ -45.39M
Net Income
$ -130.87M$ -70.80M$ -124.51M$ -63.91M$ -52.65M
Per Share Metrics
Basic EPS
$ -2.32$ -1.82$ -3.34$ -2.22$ -4.10
Diluted EPS
$ -2.32$ -1.82$ -3.34$ -2.22$ -4.10
Weighted Average Shares Outstanding
56.30M 38.90M 37.32M 28.76M 12.84M
Weighted Average Shares Outstanding (Diluted)
56.30M 38.90M 37.32M 28.76M 12.84M
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis